CellaVision AB (publ) CEVI.ST

Nasdaq Stockholm · Healthcare · Medical Devices

CellaVision AB (publ) closed at 174.80 SEK on 2026-09-25. Over the past year the share has returned +0.1% including dividends. The dividend yield over the last 12 months is 1.6%.

Backtest this stock Charts and annual figures

Price (SEK)

174.80

+5.1% today

1 month

+6.1%

1 year

+0.1%

5 years

−54%

Market cap (SEK)

4.2 bn

Div. yield

1.6%

Returns include dividends. Prices from Yahoo Finance, updated every weekday evening.

Share price, 5 years (SEK)

Dividends per share (SEK)

2026	2.75
2025	2.50
2024	2.25
2023	2.25
2022	2.00

Key figures

P/E	27.2
P/B	4.7
EV / EBITDA	17.0
Net debt / EBITDA	−0.7
Return on equity	17.2%
Profit margin	20.2%
Beta 1Y	0.82
Volatility	34%
From 52-week high	−7%

Ratios use the latest annual report that was public 90 days after the year end.

In popular strategies

None of the ten popular strategies buys CEVI.ST today. See the strategies

Same sector

AstraZeneca PLC AZN.ST
Swedish Orphan Biovitrum AB (publ) SOBI.ST
Getinge AB (publ) GETI-B.ST
Sectra AB (publ) SECT-B.ST
Medicover AB (publ) MCOV-B.ST
Camurus AB (publ) CAMX.ST
BioArctic AB (publ) BIOA-B.ST
Asker Healthcare Group AB (publ) ASKER.ST

Not investment advice. Figures may contain errors from the data source.